• Thumbnail for Celgene
    Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in...
    32 KB (2,807 words) - 19:07, 12 September 2024
  • biotechnology company Celgene for $9 billion. In November 2019, Bristol-Myers Squibb (BMS) announced that it has completed its acquisition of Celgene. In December...
    9 KB (828 words) - 22:34, 22 January 2024
  • Thumbnail for Bristol Myers Squibb
    (formerly Squibb, near Princeton), Summit, New Jersey, formerly HQ of Celgene, New Brunswick, New Jersey, Redwood City, California, and Seville in Spain...
    96 KB (7,620 words) - 18:57, 12 September 2024
  • delivery vehicle. It is manufactured and sold in the United States by Celgene under the trade name Abraxane where it is designated as an orphan drug...
    9 KB (716 words) - 09:40, 4 August 2024
  • Thumbnail for Apremilast
    insurances about €11,000 as of 2018. Celgene made Otezla available in the UK in 2015. In 2019, Amgen acquired Otezla from Celgene for $13.4 billion. In 2020, Otezla...
    21 KB (1,840 words) - 10:50, 19 August 2024
  • (thalidomide) capsule [Celgene Corporation]". DailyMed. Celgene Corporation. November 2013. Retrieved 17 January 2014. "UK Label: Thalidomide Celgene 50 mg Hard Capsules"...
    3 KB (187 words) - 15:46, 26 July 2023
  • Thumbnail for Ozanimod
    [better source needed] Celgene Corp acquired Receptos along with its intellectual property in 2015. Bristol Myers Squibb acquired Celgene in 2019 (and with...
    33 KB (3,240 words) - 13:34, 27 January 2024
  • with Celgene to continue the development and commercialization of the cancer drug BGB-A317, also known as tislelizumab. BeiGene also acquired Celgene's operations...
    25 KB (2,301 words) - 16:41, 12 September 2024
  • Thumbnail for Thalidomide
    version with no other change in the molecule is called chiral inversion. Celgene Corporation originally synthesized thalidomide using a three-step sequence...
    76 KB (7,428 words) - 20:03, 8 September 2024
  • Thumbnail for Bob Hugin
    is an American businessman who was formerly the executive chairman of Celgene, a biopharmaceutical company. Hugin was the Republican nominee in the 2018...
    28 KB (2,091 words) - 03:14, 6 June 2024
  • develop muscle. In 2008 Acceleron and Celgene started a partnership to jointly develop and market ACE-011 in which Celgene paid Acceleron $50 million up front...
    13 KB (1,094 words) - 21:54, 14 August 2024
  • Thumbnail for Lenalidomide
    The first synthesis of lenalidomide was disclosed in patents filed by Celgene. Methyl 2-methyl-3-nitrobenzoate is brominated using N-bromosuccinimide...
    29 KB (2,483 words) - 05:43, 9 August 2024
  • metastatic breast cancer. In 2010, Abraxis BioScience was acquired by Celgene Corporation. Abraxis was incorporated in 2001 in Los Angeles. It was formerly...
    8 KB (490 words) - 22:35, 22 October 2023
  • Thumbnail for Kirkland & Ellis
    Jeffrey Wigand. Bristol-Myers Squibb in its US$90 billion acquisition of Celgene, the largest biopharmaceutical deal in history by terms of transaction...
    38 KB (3,457 words) - 17:31, 8 August 2024
  • Thumbnail for Evercore
    Petroleum, and Bristol-Myers Squibb on its $74 billion acquisition of Celgene Corporation in the largest M&A deal of the year. In 2020 Evercore advised...
    16 KB (1,439 words) - 18:16, 2 August 2024
  • reappraisal for the use of Abraxane in the UK. This was in response to Celgene putting forward a Patient Access Scheme (PAS) proposal, which would bring...
    7 KB (716 words) - 18:09, 29 August 2024
  • Thumbnail for Editas Medicine
    the end of developing cancer therapeutics. Juno was later acquired by Celgene, which was in turn acquired by Bristol Myers Squibb. The company announced...
    15 KB (1,225 words) - 08:02, 9 May 2024
  • Life Sciences Funding Initiative and venture capital partners, including Celgene, General Electric Ventures, and Eli Lilly, committed a minimum of US$100 million...
    20 KB (1,296 words) - 08:38, 16 August 2024
  • Thumbnail for Manhattan
    Life Sciences Funding Initiative and venture capital partners, including Celgene, General Electric Ventures, and Eli Lilly, committed a minimum of US$100 million...
    306 KB (30,836 words) - 13:42, 12 September 2024
  • Thumbnail for Nasdaq-100
    classes of stock of 21st Century Fox. On November 21, Exelon replaced Celgene. On December 13, Nasdaq announced that as a result of the annual re-ranking...
    59 KB (5,031 words) - 16:57, 12 September 2024
  • Thumbnail for Milan
    global companies, such as Accenture, AXA, Bank of America, BNP Paribas, Celgene, China Construction Bank, Deutsche Bank, FM Global, Herbalife, Amazon,...
    208 KB (19,258 words) - 22:00, 14 September 2024
  • syndromes. It was developed by Acceleron Pharma in collaboration with Celgene. The U.S. Food and Drug Administration (FDA) granted approval for luspatercept–aamt...
    11 KB (799 words) - 20:36, 19 August 2024
  • launch partnership with Celgene, developing metabolic immuno-oncology therapies and licensing AG-221 as well as AG-881 to Celgene, potentially garnering...
    7 KB (518 words) - 16:55, 4 May 2024
  • Precision Genome Engineering Inc. for up to $156 million. In November 2017, Celgene, now Bristol-Myers Squibb (BMS), announced a collaboration with bluebird...
    15 KB (1,348 words) - 00:12, 3 May 2024
  • Thumbnail for Condom
    transplant published in New England Journal of Medicine" (Press release). AAAS. Celgene Corporation. 4 September 2014. Archived from the original on 26 October...
    128 KB (13,207 words) - 21:27, 11 September 2024
  • Retrieved 2015-03-17. "Celgene, Kinder Morgan and Actavis . . " (PDF). www.spice-indices.com. 2015-03-13. Retrieved 2015-03-13. "Celgene, Kinder Morgan and...
    197 KB (6,423 words) - 16:15, 14 September 2024
  • scheme. Through counsel, Celgene also told the patent office that CFAD had threatened to challenge its patents unless Celgene met CFAD's demands. In October...
    61 KB (5,841 words) - 16:25, 2 September 2024
  • Thumbnail for Fedratinib
    S2CID 22723501. "Celgene to Acquire Impact Biomedicines, Adding Fedratinib to Its Pipeline of Novel Therapies for Hematologic Malignancies". Celgene (Press release)...
    10 KB (691 words) - 05:40, 18 July 2024
  • Buy Celgene in $74 Billion Cancer-Drug Bet". Bloomberg News. 3 January 2019. Archived from the original on 2019-01-03. Retrieved 2019-01-03. "Celgene, Bristol-Myers...
    323 KB (11,888 words) - 21:44, 12 September 2024
  • cosmetics powerhouse". CNBC. May 23, 2019. Retrieved December 16, 2019. "Celgene, Kinder Morgan and Actavis Set to Join the S&P 100; Several Constituent...
    30 KB (2,776 words) - 00:12, 14 September 2024